Candace Wang

University of California, San Francisco — United States

Medicine · Health Sciences

13h-index2.7kcitations25works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(14), Animal Virus Infections Studies(7), SARS-CoV-2 detection and testing(7), COVID-19 Clinical Research Studies(5), Hemoglobinopathies and Related Disorders(5)

Publications25 total

Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California
Nature Microbiology·2022· 46 cited
Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California
2021· 13 citedOpen Access
Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant
Cell·2021· 537 citedOpen Access
Introduction, Transmission Dynamics, and Fate of Early Severe Acute Respiratory Syndrome Coronavirus 2 Lineages in Santa Clara County, California
The Journal of Infectious Diseases·2021· 2 citedOpen Access
Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant
Zenodo (CERN European Organization for Nuclear Research)·2021Open Access
Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant
Zenodo (CERN European Organization for Nuclear Research)·2021Open Access
Emergence and rapid transmission of SARS-CoV-2 B.1.1.7 in the United States
Cell·2021· 370 citedOpen Access
Transmission, infectivity, and antibody neutralization of an emerging SARS-CoV-2 variant in California carrying a L452R spike protein mutation
2021· 247 citedOpen Access
Genomic epidemiology identifies emergence and rapid transmission of SARS-CoV-2 B.1.1.7 in the United States
2021· 106 citedOpen Access
Rapid pathogen detection by metagenomic next-generation sequencing of infected body fluids
Nature Medicine·2020· 652 citedOpen Access
SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood
Nature Communications·2020· 181 citedOpen Access
Genomic surveillance reveals multiple introductions of SARS-CoV-2 into Northern California
Science·2020· 300 citedOpen Access
SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood from the San Francisco Bay Area
2020· 85 citedOpen Access
Associations of Early COVID-19 Cases in San Francisco With Domestic and International Travel
Clinical Infectious Diseases·2020· 10 citedOpen Access
A Genomic Survey of SARS-CoV-2 Reveals Multiple Introductions into Northern California without a Predominant Lineage
2020· 36 citedOpen Access
Cavernous malformations are rare sequelae of stereotactic radiosurgery for brain metastases
Acta Neurochirurgica·2018· 9 cited
Efficacy and Safety of Deferasirox Across Underlying Non-Transfusion-Dependent Thalassemia Syndromes: 1-Year Results from the Thetis Study
Blood·2015
Optimizing Iron Chelation Therapy with Deferasirox for Non-Transfusion-Dependent Thalassemia Patients: 1-Year Results from the Phase IV, Open-Label Thetis Study
Blood·2015
Efficacy and Safety of Deferasirox in Chinese Patients with Non-Transfusion-Dependent Thalassemia: 1-Year Results from the Thetis Study
Blood·2015· 2 cited
Optimising iron chelation therapy with deferasirox for non-transfusion-dependent thalassaemia patients: 1-year results from the THETIS study
Blood Cells Molecules and Diseases·2015· 27 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Charles Y. Chiu(14), Venice Servellita(12), Xianding Deng(11), Alicia Sotomayor-González(11), Steve Miller(10), Kevin Reyes(8), Scot Federman(7), Wei Gu(6), Elaine Hsu(6), Dustin R. Glasner(6), Debra A. Wadford(6), Guixia Yu(4), Amelia S. Gliwa(4), Joanna Balcerek(4), Jessica Streithorst(4), Carlos Anaya(4), Stacia K. Wyman(4), Karthik Gangavarapu(4), Mark Zeller(4), Catelyn Anderson(4)